United Therapeutics
UTHR
#1026
Rank
HK$172.27 B
Marketcap
HK$3,809
Share price
1.08%
Change (1 day)
30.75%
Change (1 year)

Revenue for United Therapeutics (UTHR)

Revenue in 2025 (TTM): HK$24.38 Billion

According to United Therapeutics's latest financial reports the company's current revenue (TTM ) is HK$24.35 Billion. In 2024 the company made a revenue of HK$22.33 Billion an increase over the revenue in the year 2023 that were of HK$18.17 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for United Therapeutics from 1999 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$24.38 B9.15%
2024 HK$22.33 B22.89%
2023 HK$18.17 B20.15%
2022 HK$15.12 B15.11%
2021 HK$13.14 B14.3%
2020 HK$11.49 B1.91%
2019 HK$11.28 B-11.48%
2018 HK$12.74 B-5.43%
2017 HK$13.47 B8.72%
2016 HK$12.39 B9.13%
2015 HK$11.36 B13.67%
2014 HK$9.99 B15.39%
2013 HK$8.66 B21.98%
2012 HK$7.10 B23.01%
2011 HK$5.77 B23.9%
2010 HK$4.65 B62.46%
2009 HK$2.86 B31.83%
2008 HK$2.17 B32.26%
2007 HK$1.64 B32.47%
2006 HK$1.24 B38.14%
2005 HK$0.89 B57.15%
2004 HK$0.57 B38.32%
2003 HK$0.41 B76.02%
2002 HK$0.23 B425.56%
2001 HK$44.69 M179.63%
2000 HK$15.98 M311.46%
1999 HK$3.88 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eli Lilly
LLY
HK$462.55 B 1,799.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$226.42 B 829.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$130.59 B 436.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
HK$488.76 B 1,906.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
HK$85.80 B 252.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
HK$0.67 B-97.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$329.69 B 1,253.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cardinal Health
CAH
HK$1.824 T 7,389.77%๐Ÿ‡บ๐Ÿ‡ธ USA